Centre Hospitalier De Boulogne Sur Mer — Clinical Trial Site

34 Registered trials

16 Currently recruiting

Organisation

Centre Hospitalier De Boulogne Sur Mer

Location

Boulogne-Sur-Mer, France

Identifier

ORG-100046138

Address

12 Allee Jacques Monod, 62200, France

Departments

Anesthésie-réanimation
digestive oncology
Gastroenterology
Hématologie
Medical Oncology
Néphrologie
Néphrologie et Hémodialyse
Nephrology
Onco-hématologie et de gastro-entérologie
Oncologie
Oncologie Médicale
Oncology
Service d'Oncologie digestive
Service de Néphrologie
Service de Néphrologie et Hémodialyse
Service de Nephrologie et Medecine Interne
Service de Neurologie - Unité Neurovasculaire
Service de Pneumologie

Clinical trials at this site (34)

Search interface

PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien… Ended

2022-501217-31-00 Hepatocellular carcinoma 10 2023-03-09
Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca… Ended

2024-513707-14-00 Only patients with oncologic locally advanced or metast 5 2022-01-14
MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended

2024-512269-14-00 GIant cell Arteritis 5 2020-01-27
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, … Ended

2024-512470-10-00 End-stage Renal disease 11 2018-02-02
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended

2024-517489-41-00 High-risk stage III colon cancer 5 2017-03-27
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Ended

2024-510704-37-00 ER+/HER2- metastatic breast cancer 5 2017-03-22
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement Halted

2024-519620-24-01 ANCA-associated vasculitis 5 2026-06-01
Detection of tumor DNA in the blood of patients receiving standard therapy for hormone receptorpositive (HR+) non-HER2 expressing (HER2-) me… Ended

2022-502372-22-01 Metastatic Breast Cancer HR+, HER2- 4 2023-10-19
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18